CD300A
CD300A (CD300a molecule, also known as Irp60, CMRF35H and CMRF35-like molecule 8) is a cell surface inhibitory receptor of the CD300 family, found on leukocytes. It helps to dampen immune cell activation, including NK cell cytolytic activity and mast cell degranulation. Browse Assay Genie's current range of CD300A research reagents below, or read on for the biology behind the target.
CD300A is an inhibitory receptor that may contribute to the down-regulation of cytolytic activity in natural killer (NK) cells and to the down-regulation of mast cell degranulation. It also acts on innate immune signalling: CD300A negatively regulates Toll-like receptor (TLR) signalling mediated by MYD88, but not TRIF, through activation of the phosphatase PTPN6. This places the receptor as a brake on several leukocyte response pathways.
The CD300A gene encodes a member of the CD300 glycoprotein family of cell surface proteins found on leukocytes involved in immune response signalling pathways. The protein is localised to the cell membrane. In HGNC, the gene belongs to the CD molecules, V-set domain containing and CD300 molecule family groups. Researchers studying the CD300A gene will find that multiple transcript variants encoding different isoforms have been described. The gene lies on chromosome 17 in a cluster with all but one of the other CD300 family members.
The receptor has been catalogued under several names, including CD300a antigen, Irp60, CMRF35H, CMRF-35-H9, IRC1, IRC2 and IGSF12. Orthologues are annotated in mouse and rat, both as Cd300a, which allows the receptor to be studied in rodent models. Because CD300A restrains activation in more than one cell type, it is a useful target for work on how leukocytes limit their own responses.
CD300A may contribute to down-regulating NK cell cytolytic activity, making it relevant to studies of how inhibitory receptors set NK cell activation thresholds.
The receptor is implicated in down-regulating mast cell degranulation, supporting research into the control of mast cell responses.
CD300A negatively regulates MYD88-mediated TLR signalling through PTPN6 activation, a pathway of interest for innate immune signalling studies.
As a CD300 family glycoprotein on leukocytes, CD300A is a reference point for comparing family members and immune response signalling pathways.
CD300A is an inhibitory receptor on the cell membrane. It may contribute to down-regulating NK cell cytolytic activity and mast cell degranulation. It also negatively regulates MYD88-mediated TLR signalling, but not TRIF-mediated signalling, through activation of PTPN6.
CD300A is also called CMRF35-like molecule 8, CD300a antigen, Irp60, CMRF35H, CMRF-35-H9, IRC1, IRC2 and IGSF12. NCBI Gene reports that multiple transcript variants encoding different isoforms have been found for this gene.
Mouse and rat both have a Cd300a orthologue. In humans, CD300A belongs to the CD300 family, whose genes sit mostly in a cluster on chromosome 17, with all but one family member in that cluster. Check the datasheet of any product for its validated reactivity.
Other CD molecules, inhibitory receptors and leukocyte markers relevant to immune signalling research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UGN4; product specifications from Assay Genie datasheets.